The executive vice president and general counsel of Johnson & Johnson, Michael Ullman, MD, plans to retire by the end of 2022 and will be succeeded by Elizabeth Forminard, effective Oct. 17.
Dr. Ullman is retiring after 33 years of working at J&J, where he's served in the legal sector and has been general counsel for the past decade, according to a July 18 press release.
"For three decades, Mike set the standard for Credo leadership at the company," Johnson & Johnson CEO Joaquin Duato said in a statement. "Throughout his tenure, Mike has guided the company through an evolving global environment with respect and clarity, always keeping our patients and customers at the center of all decisions."
With a 16-year tenure at the business, Ms. Forminard previously served as general counsel to pharmaceutical, consumer health and MedTech departments.